Single-Pill Combinations in the Treatment of Hypertension in Adults: Beyond Convenience.

Benoit Imbeault, Michel Vallée

Journal: Canadian journal of diabetes 2018;42(2):205-208

PMID: 29602409

Abstract

Adequate blood pressure control in patients with hypertension remains the pillar of cardiovascular-event prevention. Smoking cessation, reduced dietary salt intake, physical exercise and weight loss contribute to better blood pressure control and reduced cardiovascular morbidity, but alone, they are often insufficient in doing so, and their success is highly dependent on individual patient motivation. Pharmacologic therapy, thus, remains necessary for most patients, and our conception of the optimal way of approaching this therapy has evolved over the past decade. Traditionally, monotherapy using a first-line drug was initiated and uptitrated, with the addition of other antihypertensive agents as needed. The latest Hypertension Canada guidelines, however, now recommend first-line treatment with single-pill combinations in patients without compelling indications for treatment. In this review, we discuss the evidence behind this recommendation and how single-pill combinations can improve patient care.

Copyright © 2018 Diabetes Canada. Published by Elsevier Inc. All rights reserved.

Address: Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada.; Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.